Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character

Fig. 1

Differential transcription of genes encoding HSPGs. a, b, Relative transcript abundance of mRNAs for healthy tissues (gray bars) and tumors (black bars). Genes that show significant differences in their transcription levels are highlighted. a, Non-metastatic LSCRCs. 1: syndecan-1 (p < 0.05); 4: perlecan (p < 0.05); 5: collagen XVIII (p < 0.05); serglycin (p < 0.05). b, Metastatic LSCRCs. 1: syndecan-1 (p < 0.035); 2: glypican-4 (p < 0.05); 3: glypican-6 (p < 0.05); 4: perlecan (p < 0.05); 8: serglycin (p < 0.05). c, Relative expression ratio of genes that show statistically significant differences in expression in non-metastatic (●) or metastatic (■) CRCs. Values on the Y axis are on a logarithmic scale and the spreads represent the standard deviations

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us